Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?

Ahmed, Faria; Jo, Dong-Hyeon; Lee, Seung-Hwan

Ahmed, Faria; Jo, Dong-Hyeon; Lee, Seung-Hwan.

Ahmed F; Department of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada.
Jo DH; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Lee SH; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Front Immunol ; 11: 586765, 2020.

Article in English | MEDLINE | ID: covidwho-1389166

Subject(s)

COVID-19/immunology; Killer Cells, Natural/immunology; SARS-CoV-2/immunology; Apoptosis/immunology; COVID-19/pathology; Cytokine Release Syndrome/immunology; Cytokine Release Syndrome/pathology; Humans

Keywords

COVID-19; SARS-CoV-2 infection; immunomodulatory; immunotherapy; natural killer cells

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Killer Cells, Natural / SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Front Immunol Year: 2020 Document Type: Article Affiliation country: FIMMU.2020.586765

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google